查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1936787

全球左心耳封堵器市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Left Atrial Appendage Closure Device Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計左心耳封堵器市場規模將從 2025 年的 32.4 億美元成長到 2034 年的 165.4 億美元，2026 年至 2034 年的複合年成長率為 19.87%。

由於心房顫動（AF）盛行率不斷上升以及對有效中風預防策略的需求日益成長，全球左心耳封堵器市場預計將迎來顯著成長。左心耳封堵器旨在封鎖左心耳，而左心耳是心房顫動患者血栓形成的主要來源，從而降低中風風險。隨著醫療機構尋求改善患者預後並最大限度地減少抗凝血治療相關併發症，左心耳封堵器的應用預計將顯著增加，從而推動這一專業市場的創新和投資。

此外，器械技術和手術流程的進步預計將進​​一步推動市場發展。微創左心耳封堵器械和改良輸送系統的研發提高了手術的安全性和有效性，使其適用於更廣泛的病患群體。此外，心臟超音波圖等影像技術的應用也改善了手術指導和治療效果。隨著以患者為中心的醫療模式日益普及，對具有更高安全性和長期療效的創新左心耳封堵解決方案的需求將持續成長。

此外，對中風預防的日益重視以及對心房顫動認知的不斷提高，預計將影響左心耳封堵器市場的未來發展。隨著患者對治療方案了解的增多，對能夠降低心房顫動相關風險的有效解決方案的需求也日益成長。醫療設備製造商、心臟病專家和醫療機構之間的合作對於推動這些進步至關重要，並確保左心耳封堵器市場始終處於心血管創新領域的前沿。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球左心耳封堵器市場（依產品分類）

  • 市場分析、洞察與預測
  • 心內左心耳封堵裝置
  • 心外膜左心耳封堵裝置

5. 全球左心耳封堵器市場（依手術類型分類）

  • 市場分析、洞察與預測
  • 經皮
  • 外科

6. 全球左心耳封堵器市場（依最終用途分類）

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 其他

7. 全球左心耳封堵器市場（依地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • AtriCure
    • Boston Scientific Corporation
    • Lepu Medical Technology
    • LifeTech Scientific
    • MicroPort Scientific Corporation
    • Nanjing YDB Technology
    • Shanghai Push Medical Device Technology
    • Biosense WebsterInc
    • Aegis Medical Group
簡介目錄
Product Code: VMR11212621

The Left Atrial Appendage Closure Device Market size is expected to reach USD 16.54 Billion in 2034 from USD 3.24 Billion (2025) growing at a CAGR of 19.87% during 2026-2034.

The global left atrial appendage (LAA) closure device market is set to experience substantial growth, driven by the increasing prevalence of atrial fibrillation (AF) and the rising demand for effective stroke prevention strategies. LAA closure devices are designed to occlude the left atrial appendage, a common source of thrombus formation in patients with AF, thereby reducing the risk of stroke. As healthcare providers seek to enhance patient outcomes and minimize the complications associated with anticoagulation therapy, the adoption of LAA closure devices is expected to rise significantly, fostering innovation and investment in this specialized market.

Moreover, advancements in device technology and procedural techniques are anticipated to further boost the market. The development of minimally invasive LAA closure devices and improved delivery systems is enhancing the safety and efficacy of the procedure, making it more accessible to a broader patient population. Additionally, the integration of imaging technologies, such as transesophageal echocardiography, is improving procedural guidance and outcomes. As the focus on patient-centered care continues to grow, the demand for innovative LAA closure solutions that offer improved safety profiles and long-term efficacy will continue to rise.

In addition, the increasing emphasis on stroke prevention and awareness of atrial fibrillation is expected to shape the future of the LAA closure device market. As patients become more informed about their treatment options, there is a growing demand for effective solutions that can mitigate the risks associated with AF. Collaborative efforts between medical device manufacturers, cardiologists, and healthcare organizations will be essential in driving these advancements, ensuring that the LAA closure device market remains at the forefront of cardiovascular innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Endocardial LAA Devices
  • Epicardial LAA Devices

By Procedure

  • Percutaneous
  • Surgical

By End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • Abbott Laboratories, AtriCure, Boston Scientific Corporation, Lepu Medical Technology, LifeTech Scientific, MicroPort Scientific Corporation, Nanjing YDB Technology, Shanghai Push Medical Device Technology, Biosense Webster, Inc, Aegis Medical Group

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET: BY PRODUCT 2022-2034 (USD MN and K Units)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Endocardial LAA Devices Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.3. Epicardial LAA Devices Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET: BY PROCEDURE 2022-2034 (USD MN and K Units)

  • 5.1. Market Analysis, Insights and Forecast Procedure
  • 5.2. Percutaneous Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.3. Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET: BY END USE 2022-2034 (USD MN and K Units)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET: BY REGION 2022-2034(USD MN and K Units)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.2.1 By Product
    • 7.2.2 By Procedure
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.3.1 By Product
    • 7.3.2 By Procedure
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.4.1 By Product
    • 7.4.2 By Procedure
    • 7.4.3 By End Use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.5.1 By Product
    • 7.5.2 By Procedure
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.6.1 By Product
    • 7.6.2 By Procedure
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott Laboratories
    • 9.2.2 AtriCure
    • 9.2.3 Boston Scientific Corporation
    • 9.2.4 Lepu Medical Technology
    • 9.2.5 LifeTech Scientific
    • 9.2.6 MicroPort Scientific Corporation
    • 9.2.7 Nanjing YDB Technology
    • 9.2.8 Shanghai Push Medical Device Technology
    • 9.2.9 Biosense WebsterInc
    • 9.2.10 Aegis Medical Group